Ambroise Magistretti
About Ambroise Magistretti
Ambroise Magistretti is a co-founder and co-CEO of GliaPharm SA, where he has worked since 2019, and a founding team member at MindMaze since 2006. He holds multiple degrees in fields such as Genome Sciences, Biochemistry, and Finance, and has extensive experience in corporate development and business management in the biotech sector.
Work at GliaPharm SA
Ambroise Magistretti serves as Co-Founder and Co-CEO at GliaPharm SA, a position he has held since 2019. He has been instrumental in the company's development in the Geneva Area, Switzerland. Prior to his current role, he worked as Co-Founder and CFO from 2016 to 2019, where he focused on business development. His contributions have been significant in shaping the company's strategic direction and operational framework.
Work at MindMaze
Since 2006, Ambroise Magistretti has been a Founding Team Member, Corp. Dev., and Advisor at MindMaze in Switzerland. His long-term involvement with the company highlights his commitment to advancing its mission. In this role, he has contributed to corporate development initiatives that align with the company's vision in the technology and healthcare sectors.
Education and Expertise
Ambroise Magistretti holds a Master's degree in Genome Sciences/Genomics from the University of Lausanne, where he studied from 2006 to 2008. He also completed a Certificate of Advanced Studies in Management of Biotech and Medtech Ventures at EPFL in 2016. Additionally, he earned an Online Certificate in Medical Neuroscience from Duke University in 2017 and a Chartered Alternative Investment Analyst designation from CAIA Association in 2013. His educational background supports his expertise in biotechnology, management, and finance.
Background
Ambroise Magistretti completed his Bachelor of Science in Biochemistry at UCL from 2002 to 2005. His academic journey laid the foundation for his career in the biotechnology and healthcare industries. His diverse educational experiences have equipped him with a broad understanding of scientific and business principles.